Clinical Chemistry, Malmö
1021 – 1030 of 1294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
(
- Contribution to journal › Article
-
Mark
EGF-like domains
2002)(
- Chapter in Book/Report/Conference proceeding › Entry for encyclopaedia/dictionary
-
Mark
Large-scale randomized prostate cancer screening trials : Program performances in the european randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
(
- Contribution to journal › Article
-
Mark
Innovators in urology
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Factor V and thrombotic disease: description of a janus-faced protein.
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
(
- Contribution to journal › Article
-
Mark
Computer-supported detection of M-components and evaluation of immunoglobulins after capillary electrophoresis
(
- Contribution to journal › Article
-
Mark
Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing
(
- Contribution to journal › Article
-
Mark
Structural requirements for the complement regulatory activities of C4BP
(
- Contribution to journal › Article
-
Mark
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing
(
- Contribution to journal › Article